| ||
Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative ... PharmaLive (press release) (subscription) Pursuant to the collaboration agreement, NeuroVive will grant Sihuan Pharmaceutical an exclusive license to develop, market and sell CicloMulsion® and NeuroSTAT® in China, as well as the intellectual property rights and knowhow in connection with the ... See all stories on this topic » | ||
| ||
Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board PharmaLive (press release) (subscription) 20, 2012 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCBB: OHRP) today announced the addition of two prominent ophthalmologists to its Scientific Advisory Board ("SAB") comprised of leading retinal ophthalmology experts to assist in advancing the ... See all stories on this topic » | ||
Validus Pharma gets rights to six Novartis drugs in USA The Pharma Letter USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired USs rights to six well-known product lines, patent protection on which has now expired, from the US subsidiary of Swiss drug major Novartis ... See all stories on this topic » | ||
RM1.1b income for pharmaceutical seen Business Times - Malaysia Pharmaceutical Research Centre and PROTEMP Exhibitions Sdn Bhd and supported by the Ministry of Health, Ministry of Agriculture and Agro-Based Industries and Universiti Teknologi MARA. The two-day event brings together leading experts to share ... See all stories on this topic » | ||
Rising Pharmaceuticals to launch generic version of Gris-PEG(R) Pharmaceutical Business Review Rising Pharmaceuticals is a finished dosage form generics subsidiary of ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals. Share: Delicious · Digg · submit to reddit ... See all stories on this topic » | ||
Par Pharmaceutical Announces Quarterly Conference Call MarketWatch (press release) WOODCLIFF LAKE, N.J., Nov. 20, 2012 /PRNewswire via COMTEX/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, November 28, 2012, at 10:00 A.M. EST to review its results of operations for the ... See all stories on this topic » | ||
UBC professor wins Canada's top pharmaceutical research award Phys.Org (press release) UBC microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honour in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unravelling ... See all stories on this topic » | ||
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary endpoint Pharmaceutical Business Review Select a Pharmaceutical sector, ------------------------, Fine & Speciality Chemicals, Manufacturing, Process & Production, OTC, ------------------------, Drug Delivery, Drug Discovery & Development, ------------------------, Clinical Trials, Contract ... See all stories on this topic » | ||
FDA backs new indication for GlaxoSmithKline's Promacta The Pharma Letter The drug was developed in collaboration with the USA's Ligand Pharmaceuticals (Nasdaq: LGND). Offers doctors a tool to address low platelet challenge. "Chronic hepatitis C is a significant public health issue," said Paolo Paoletti, president ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment